Thursday, June 12, 2025

Cytek Launches Aurora Evo Flow Cytometer Boosting Throughput and Automation

Similar articles

Cytek Biosciences unveils the Aurora™ Evo flow cytometer, enhancing its esteemed Aurora system with improved sample processing and automation features. This latest innovation aims to meet the escalating demands of contemporary cell analysis research.

Advanced Features Enhance Research Capabilities

The Aurora Evo integrates Cytek’s renowned Full Spectrum Profiling™ technology, enabling high-resolution data acquisition across a broad range of flow rates. Researchers can now perform large-scale multicolor experiments with increased speed, acquiring samples twice as fast as previous models without sacrificing data integrity.

Subscribe to our newsletter

Built-In Small Particle Detection and Automation

A standout addition to the Aurora Evo is the native small particle detection, previously an optional feature, now standard. This advancement allows for the precise identification of extracellular vesicles, viruses, and nanoparticles directly on the instrument. Furthermore, the system’s automation capabilities streamline workflows through automated maintenance, startup, and shutdown processes, significantly reducing downtime and enhancing productivity.

Inferences:

  • Increased throughput may lead to higher productivity in high-demand research environments.
  • Built-in small particle detection expands the instrument’s application scope, attracting diverse research fields.
  • Automation features likely reduce operational costs and minimize human error in data collection.

The Aurora Evo’s design emphasizes harmonization, ensuring consistency and reproducibility of data across different laboratories and timeframes. Its ability to detect both small and large particles on a single platform allows scientists to explore a wider array of biological questions with confidence and precision.

Cytek Biosciences positions the Aurora Evo as a critical tool for advancing cell analysis, supporting breakthroughs in immunology, oncology, and other biomedical sciences. The system’s enhanced capabilities are expected to drive further adoption of spectral flow cytometry in research institutions globally.

Attendees at CYTO 2025 will witness the Aurora Evo’s capabilities firsthand, with live demonstrations set to highlight its performance and user-friendly design. This launch underscores Cytek’s commitment to providing cutting-edge technology that empowers researchers to accelerate their scientific discoveries.

Equipping laboratories with high-performance, automated flow cytometry tools like the Aurora Evo not only boosts research efficiency but also facilitates more comprehensive and accurate data analysis. By integrating these advancements, Cytek ensures that scientists have the resources needed to push the boundaries of cellular research.

Source

You can follow our news on our Telegram, LinkedIn and Youtube accounts.


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article